[15] In August 2024, the SURMOUNT-1 three-year study (176-week treatment period) found that tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight
And we know that taking these drugs if it allows you to lose weight, get your A1C better, get your blood pressure better will have tremendous impact on your overall health and well-being. Vision loss is rare given how many millions of people are taking GLP-1 medicines, says Dr
Genetic variations in GLP-1 receptor (GLP1R), GIP receptor (GIPR), and appetite-regulation genes (FTO, MC4R) can predispose individuals to greater weight gain and reduced satiety signals
They can be used instead of, or alongside, Metformin to manage PCOS symptoms, particularly when weight loss is a main goal
4 showed the scatter plots for the causal estimation of GLP-1RAs on the risk of SA in discovery and replication datasets